SELLAS Life Sciences Group Inc. Shares Close the Week 21.7% Higher - Weekly Wrap
The company saw its shares close the week 21.7% higher than last week, with trading volume higher than its 30 day average.
Mar 12, 2021 by Kwhen Finance Editors
SELLAS Life Sciences Group Inc. shares closed this week 21.7% higher than it did at the end of last week. The stock is currently up 90.2% year-to-date, up 494.1% over the past 12 months, and down 30.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.7%, and the S&P 500 rose 3.8%.
Trading Activity
- Shares traded as high as $11.13 and as low as $8.21 this week.
- Trading volume this week was 0.7% higher than the 10-day average and 29.0% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| SELLAS Life Sciences Group Inc. | 4.3 | 90.2 | 494.1 | ||
| Dow Jones Industrial Average | 0.5 | 8.2 | 45.2 | -0.3 | 84.0 |
| S&P 500 Index | 0.6 | 6.0 | 49.9 | -0.6 | 83.0 |
| Health Care | 0.7 | 2.0 | 32.3 | -3.3 | 62.2 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 829.3%
- The company's stock price performance over the past 12 months beats the peer average by 4203.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| SELLAS Life Sciences Group Inc. | SLS | 0 | 90.2 | 494.1 | ||
| Peer Avg | N/A | -2.2 | 9.7 | 11.5 | -18.9 | 46.2 |
| Omeros Corporation | OMER | -8.9 | 39.4 | 63.1 | -16.5 | 132.6 |
| Odonate Therapeutics Inc. | ODT | 0 | -0.6 | -17.2 | -58.9 | 52.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: